As a part of a tumor immune escape mechanism, IDO1 overexpression has been described in numerous human cancer types not only in tumor lesions by tumor cells and other components of the TME like endothelial cells, myeloid derived suppressor cells (MDSCs), DCs, but also in tumor draining lymph nodes[30, 101, 102]. The gene discussed is IDO1; the disease is neoplasm.